Future Indications

Chakravarthy, Krishnan; Golovac, Stanley; Vahedifard, Farzan

doi:10.1007/978-3-030-78032-6_16

Cited by 4 publications

(4 citation statements)

References 154 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The treatment of choice for high-grade chondrosarcoma, if amenable, is wide-margin complete surgical resection, however, in cases of low-grade lesions, curettage with or without local adjuvant treatment may be considered. Several novels and trending therapeutic targets for radiofrequency ablation (RFA) have been studied [12]. There is mounting evidence to support the use of this treatment in the spine as well [13].…”

Section: Discussionmentioning

confidence: 99%

Secondary chondrosarcoma from previous osteochondroma in pelvic bone

Hassani¹,

Rikhtehgar²,

Salmanipour³

2022

GSC Biol. Pharm. Sci.

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Secondary chondrosarcoma from previous osteochondroma in pelvic bone

Hassani¹,

Rikhtehgar²,

Salmanipour³

2022

GSC Biol. Pharm. Sci.

View full text Add to dashboard Cite

show abstract

“…For the treatment of osteoid osteomas (OO) and osteoblastomas, particularly in the appendicular skeleton, the treatment of choice is considered to be radiofrequency ablation (RFA) [22]. Several novel and trending therapeutic targets for radiofrequency ablation (RFA) have been studied [23]. There is mounting evidence to support the use of this treatment in the spine as well [24].…”

Section: Discussionmentioning

confidence: 99%

Aggressive Osteoblastoma in adolescents: Radiological case report

Bagheri¹,

Hassani²,

Salmanipour³

2022

GSC Adv. Res. Rev.

View full text Add to dashboard Cite

In this article we represent an 18-year-old female with progressive back pain and neurologic symptoms due to a large heterogenous mass centered in posterior elements of lower thoracic vertebrae with prominent soft tissue extension into paravertebral and epidural space and subsequent central cord compression along with severe adjacent inflammatory changes. Considering patient age, lesion location and characteristics, aggressive Osteoblastoma, eosinophilic granuloma, and with lower probability of Ewing sarcoma were included in the differential list, which aggressive Osteoblastoma was confirmed after pathologic examination.

show abstract

“…As an interesting future application, Neuroimaging biomarkers and innovative neuro interventions -such as neurostimulators and radiofrequency-can be used to ablate the tumor and reduce its size. Several innovative imageguided tumor ablation indications are given, which will be calibrated with imaging biomarkers [46].…”

Section: Images Biomarkers For Assessing Tumor Responsementioning

confidence: 99%

Artificial intelligence for radiomics; diagnostic biomarkers for neuro-oncology

Vahedifard¹,

Hassani²,

Afrasiabi³

et al. 2022

World J. Adv. Res. Rev.

View full text Add to dashboard Cite

Recent advances in medical image analysis have been made to improve our understanding of how disease develops, behaves, and responds to treatment. Magnetic resonance imaging (MRI) and positron emission tomography (PET) advanced imaging strategies provide structural and functional phenotypic biomarkers that correlate with key disease processes. Through radiomics and radiogenomics, ML-medical imaging has opened up new perspectives in high-grade glioma diagnosis. As a result, non-invasive and in vivo biomarkers for patient survival, tumor recurrence, and genomics are identified. Tumor genomic imaging signatures can help identify patients who benefit from targeted therapies. Molecular characterization of gliomas and prediction of their evolution would allow treatment optimization. Radiomics-based biomarkers allow for a more in-depth analysis of pathophysiologic processes and insights into diagnosing better, classifying, stratifying, and prognosticating brain tumors and assessing their response to therapy. Radiomics is a new data-driven approach that can help answer clinical questions like diagnosis, prognosis, and treatment response. With encouraging outcomes in brain tumor patients, radiomics and deep learning are still not widely used in clinical practice, requiring more extensive and practical clinical studies.

show abstract

Future Indications

Cited by 4 publications

References 154 publications

Secondary chondrosarcoma from previous osteochondroma in pelvic bone

Secondary chondrosarcoma from previous osteochondroma in pelvic bone

Aggressive Osteoblastoma in adolescents: Radiological case report

Artificial intelligence for radiomics; diagnostic biomarkers for neuro-oncology

Contact Info

Product

Resources

About